Angiotensin-(1-7) inhibits the angiotensin II-enhanced norepinephrine release in coarcted hypertensive rats

Regul Pept. 2004 Apr 15;118(1-2):45-9. doi: 10.1016/j.regpep.2003.10.026.

Abstract

Since it has been suggested that angiotensin (Ang) (1-7) functions as an antihypertensive peptide, we studied its effect on the Ang II-enhanced norepinephrine (NE) release evoked by K+ in hypothalami isolated from aortic coarcted hypertensive (CH) rats. The endogenous NE stores were labeled by incubation of the tissues with 3H-NE during 30 min, and after 90 min of washing, they were incubated in Krebs solution containing 25 mM KCl in the absence or presence of the peptides. Ang-(1-7) not only diminished the K+-evoked NE release from hypothalami of CH rats, but also blocked the Ang II-enhanced NE release induced by K+. Ang-(1-7) blocking action on the Ang II response was prevented by [D-Ala7]Ang-(1-7), an Ang-(1-7) specific antagonist, by PD 123319, an AT2-receptor antagonist, and by Hoe 140, a B2 receptor antagonist. Ang-(1-7) inhibitory effect on the Ang II facilitatory effect on K+-stimulated NE release disappeared in the presence of Nomega-nitro-L-arginine methylester and was restored by L-arginine. Our present results suggest that Ang-(1-7) may contribute to blood pressure regulation by blocking Ang II actions on NE release at the central level. This inhibitory effect is a nitric oxide-mediated mechanism involving AT2 receptors and/or Ang-(1-7) specific receptors and local bradykinin generation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin I / antagonists & inhibitors
  • Angiotensin I / pharmacology*
  • Angiotensin II / analogs & derivatives*
  • Angiotensin II / antagonists & inhibitors
  • Angiotensin II / pharmacology*
  • Animals
  • Antihypertensive Agents / antagonists & inhibitors
  • Antihypertensive Agents / pharmacology*
  • Aortic Coarctation / complications
  • Bradykinin / analogs & derivatives*
  • Bradykinin / pharmacology
  • Hypertension / etiology
  • Hypertension / physiopathology*
  • Hypothalamus / drug effects*
  • Hypothalamus / metabolism
  • Imidazoles / pharmacology
  • In Vitro Techniques
  • Nitric Oxide / metabolism
  • Norepinephrine / antagonists & inhibitors*
  • Norepinephrine / metabolism
  • Peptide Fragments / antagonists & inhibitors
  • Peptide Fragments / pharmacology*
  • Potassium / pharmacology
  • Pyridines / pharmacology
  • Rats
  • Rats, Wistar

Substances

  • 7-Ala-angiotensin (1-7)
  • Antihypertensive Agents
  • Imidazoles
  • Peptide Fragments
  • Pyridines
  • Angiotensin II
  • PD 123319
  • Nitric Oxide
  • icatibant
  • Angiotensin I
  • angiotensin I (1-7)
  • Potassium
  • Bradykinin
  • Norepinephrine